Scientific Program
10 September 2024
08:00 - 09:30 Regıstratıon
09:30 - 09:45 Welcome Ceremony
09:45 - 10:45 Keynote Lecture - Besım Ogretmen |MEDICAL UNIVERSITY OF SOUTH CAROLINA, DIRECTOR OF LIPIDOMICS CENTER, USA
Alterations of ceramide metabolism induces PD-L1 internalization and resistance to immunotherapy in breast cancer
10:45 -11:30 Shıkhar Mehrotra | MEDICAL UNIVERSITY OF SOUTH CAROLINA, USA
Targeting Thiols to Improve Anti-Tumor T Cell Therapy
11:30 - 11:50 Coffee Break
11:50 - 12:35 Ozgur Sahın | MEDICAL UNIVERSITY OF SOUTH CAROLINA, USA
From Mechanisms Of Drug Resistance To Drug Discovery
12.35 - 14:00 Lunch
14:00 - 14:30 Mutay Aslan | AKDENIZ UNIVERSITY, ANTALYA
Plasma Sphingolipidomic Profile in Insulin Resistance and Diabetic Dyslipidemia
14:30 - 15:00 Mehtap Kutlu | ESKISEHIR TECHNICAL UNIVERSITY, ESKISEHIR
Discovering New Biomarkers for Prognosis and Treatment of Malignant Mesothelioma using LC/MS/MS
15:00 - 15:30 Yesım Er Oztas | HACETTEPE UNIVERSITY, ANKARA
Future of Lipidomics in Clinical Diagnostics
15:30 - 16:30 Coffee Break and Poster Sessıon
16:30 - 17:00 Sreeparna Banerjee | MIDDLE EAST TECHNICAL UNIVERSITY
A Cross Talk Between Lipid Metabolism and Oxidative Stress in the Decision for Partial EMT in Nutrient Deprived Cancer Cells
17:00- 17:45 Short Talks -Muhammed ALI Nalbant
Relationship of Breast Cancer and Renin Angiotensin System Through ACE Gene Polymorphisms
17:00- 17:45 Short Talks - Oğuzhan Köse
Characterization of PD-L1+ B Cell Subtypes in the Tumor Microenvironment of NSCLC
17:45 - 19:00 Meet the Lecturers
19:00 Dınner (Invıted Speakers)
11 September 2024
10:00 – 10:30 Mesut bılgın | Danish Cancer Institute
Quantitative Shotgun Lipidomics: A Powerful Tool for Decoding Lipid Metabolic Disorders
10:30- 11:00 Onur CIzmecIoglu | BILKENT UNIVERSITY, ankara
Characterization of Cholesterol Biogenesis and PI3K Crosstalk for the Treatment of Anti-Hormone Therapy-Refractory Cancers
11:00 - 11:20 COFFEE BREAK AND POSTER SESSION
11:20 - 11:50 Mehmet Kocak | ISTANBUL MEDIPOL UNIVERSITY
Recent History of Cancer Mortality in Turkiye
11:50- 12:50 Flash Talks - Dr. NIHAN VERIMLI
Targeted Destruction of Micro-Tumors: A Novel Hybrid Theranostic Agent Utilizing Gold Nanoparticles and Photodynamic Therapy
12:50 - 14:00 Lunch
14:00 - 14:30 SERDAR DURDAGI | bahcesehır unıversıty
Developing Deep Learning Models for Predicting Ligand-Protein Interactions: Integrating Protein-Ligand Conformations with Directed Message Passing Neural Networks
14:30 - 15:00 Melıs Kartal Yandım | DANISH CANCER INSTITUTE, LIPIDOMICS CORE FACILITY & IZMIR UNIVERSITY OF ECONOMICS
Mcl-1 Modulation and Lipidomic Alterations: A Shotgun Lipidomics Approach in Acute Myeloid Leukemia
15:30 -16:30 - COFFEE BREAK AND POSTER SESSION
16:30 – 17:00 Jason Pıerce – Lıpıdomıcs Analysıs (Onlıne) | MEDICAL UNIVERSITY OF SOUTH CAROLINA, LIPIDOMICS CENTER, USA
Lipidomics Shared Resources: Synthesis and Analytical Core